Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy.
"A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear propertie...
Saved in:
| Online Access: |
Full text (MCPHS users only) |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Vienna :
International Atomic Energy Agency,
2015
|
| Series: | IAEA radioisotopes and radiopharmaceuticals series ;
no. 5, |
| Subjects: | |
| Local Note: | ProQuest Ebook Central |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | in00000356578 | ||
| 006 | m o d i | ||
| 007 | cr un||||||||| | ||
| 008 | 150420s2015 au a ob i000 0 eng d | ||
| 005 | 20240725200523.0 | ||
| 019 | |a 1123187029 |a 1124565463 | ||
| 020 | |a 9201210191 |q (electronic bk.) | ||
| 020 | |a 9789201210197 |q (electronic bk.) | ||
| 020 | |z 9789201038142 | ||
| 020 | |z 9201038143 | ||
| 029 | 1 | |a AU@ |b 000066432406 | |
| 035 | |a (OCoLC)907647895 |z (OCoLC)1123187029 |z (OCoLC)1124565463 | ||
| 035 | |a (OCoLC)ocn907647895 | ||
| 040 | |a COD |b eng |e rda |e pn |c COD |d EBLCP |d MERUC |d OCLCF |d EZ9 |d OCLCQ |d YDX |d OCLCQ |d K6U |d OCLCO |d OCLCQ |d OCLCO |d SXB | ||
| 050 | 4 | |a RM852 |b .Y88 2015 | |
| 082 | 0 | 4 | |a 616.07575 |2 23 |
| 245 | 0 | 0 | |a Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy. |
| 264 | 1 | |a Vienna : |b International Atomic Energy Agency, |c 2015. | |
| 300 | |a 1 online resource (301 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a IAEA radioisotopes and radiopharmaceuticals series, |x 2077-6462 ; |v no. 5 | |
| 500 | |a "STI/PUB/1662"--Title page verso | ||
| 500 | |a "January 2015"--Title page verso | ||
| 504 | |a Includes bibliographical references. | ||
| 520 | |a "A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear properties, 188Re and 90Y are considered among the most interesting radionuclides for therapy. Furthermore, they are produced through portable generators, which provide a crucial advantage toward ensuring a worldwide distribution of these radionuclides. This publication illustrates recent studies aimed at investigating efficient quality control methods to ensure both the radionuclidic purity of generator eluates, and the proper preparation of new target specific 188Re and 90Y radiopharmaceuticals for various clinical applications."--Publisher's description | ||
| 588 | 0 | |a Print version record. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Radiopharmaceuticals. | |
| 650 | 0 | |a Yttrium |x Isotopes |x Therapeutic use. | |
| 650 | 0 | |a Rhenium |x Isotopes |x Therapeutic use. | |
| 650 | 0 | |a Radioisotopes. | |
| 650 | 0 | |a Radionuclide generators. | |
| 650 | 2 | |a Radiopharmaceuticals | |
| 650 | 2 | |a Radioisotopes | |
| 650 | 2 | |a Radionuclide Generators | |
| 710 | 2 | |a International Atomic Energy Agency, |e issuing body. | |
| 776 | 0 | 8 | |i Print version: |t Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy. |d Vienna : International Atomic Energy Agency, 2015 |z 9789201038142 |w (OCoLC)907172083 |
| 830 | 0 | |a IAEA radioisotopes and radiopharmaceuticals series ; |v no. 5, |x 2077-6462 | |
| 852 | |b E-Collections |h ProQuest | ||
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=4853249 |z Full text (MCPHS users only) |t 0 |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL4853249 | ||
| 938 | |a YBP Library Services |b YANK |n 16497552 | ||
| 947 | |a FLO |x pq-ebc-base | ||
| 999 | f | f | |s 235af43e-de21-4b0e-a57e-156586a6d01f |i dc7d5b54-f3e9-4273-a4cb-b34e83e3553f |t 0 |
| 952 | f | f | |a Massachusetts College of Pharmacy and Health Sciences |b Online |c Online |d E-Collections |t 0 |e ProQuest |h Other scheme |
| 856 | 4 | 0 | |t 0 |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=4853249 |y Full text (MCPHS users only) |
